首页 > 最新文献

Current Opinion in Ophthalmology最新文献

英文 中文
How do intraocular lens materials influence the outcome of cataract surgery? 眼内晶体材料如何影响白内障手术的效果?
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-17 DOI: 10.1097/ICU.0000000000001095
Andrzej Grzybowski, Gerd U Auffarth, Benjamin R LaHood

Purpose of review: This review summarizes the evidence on the effect of intraocular lens (IOL) material on the outcomes of cataract surgery, as well as on the surgical procedure itself.

Recent findings: Differences in capsular biocompatibility between IOL materials lead to variations in capsular stability and posterior capsule opacification (PCO), while differences in uveal biocompatibility affect postoperative inflammatory response.

Summary: Refractive outcomes are affected by both incision size and the rotational stability of toric IOLs. Small incision sizes favour hydrophilic IOLs. Rotational stability of hydrophobic and hydrophilic IOLs were comparable in recent studies. Visual outcomes are affected by chromatic aberrations, dysphotopsia, lens opacifications and PCO. Hydrophilic IOLs are associated with reduced chromatic dispersion. Hydrophobic IOL opacifications are caused by sub-surface glistenings, while hydrophilic IOL opacifications are due to surface calcifications. Some surgeries, including pars plana vitrectomy and lamellar corneal transplants, were shown to increase the risk of IOL calcifications, although the mechanism is still unknown. Hydrophilic IOLs have greater ease of manipulation, greater resistance to IOL damage, and higher uveal biocompatibility. Hydrophobic IOLs show better PCO prevention than hydrophilic IOLs, and should be preferred in highly myopic eyes where Nd:YAG capsulotomy might increase the risk of retinal detachment.

综述目的:本综述总结了眼内人工晶体(IOL)材料对白内障手术效果以及手术过程本身影响的证据:不同人工晶体材料的囊内生物相容性差异会导致囊稳定性和后囊不透明(PCO)的变化,而葡萄膜生物相容性的差异会影响术后炎症反应:摘要:屈光结果受切口大小和散光人工晶体旋转稳定性的影响。小切口有利于亲水性人工晶体。在最近的研究中,疏水性和亲水性人工晶体的旋转稳定性相当。视觉效果受色差、视力障碍、晶状体混浊和 PCO 的影响。亲水性人工晶体可减少色散。疏水性人工晶体不透明是由表面下的晶状体造成的,而亲水性人工晶体不透明则是由表面钙化造成的。一些手术,包括玻璃体旁切除术和板层角膜移植术,被证明会增加人工晶体钙化的风险,但其机理尚不清楚。亲水性人工晶体更易于操作,更耐人工晶体损伤,具有更高的葡萄膜生物相容性。疏水性人工晶体比亲水性人工晶体能更好地预防 PCO,对于 Nd:YAG 包囊切开术可能会增加视网膜脱离风险的高度近视眼,疏水性人工晶体是首选。
{"title":"How do intraocular lens materials influence the outcome of cataract surgery?","authors":"Andrzej Grzybowski, Gerd U Auffarth, Benjamin R LaHood","doi":"10.1097/ICU.0000000000001095","DOIUrl":"https://doi.org/10.1097/ICU.0000000000001095","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review summarizes the evidence on the effect of intraocular lens (IOL) material on the outcomes of cataract surgery, as well as on the surgical procedure itself.</p><p><strong>Recent findings: </strong>Differences in capsular biocompatibility between IOL materials lead to variations in capsular stability and posterior capsule opacification (PCO), while differences in uveal biocompatibility affect postoperative inflammatory response.</p><p><strong>Summary: </strong>Refractive outcomes are affected by both incision size and the rotational stability of toric IOLs. Small incision sizes favour hydrophilic IOLs. Rotational stability of hydrophobic and hydrophilic IOLs were comparable in recent studies. Visual outcomes are affected by chromatic aberrations, dysphotopsia, lens opacifications and PCO. Hydrophilic IOLs are associated with reduced chromatic dispersion. Hydrophobic IOL opacifications are caused by sub-surface glistenings, while hydrophilic IOL opacifications are due to surface calcifications. Some surgeries, including pars plana vitrectomy and lamellar corneal transplants, were shown to increase the risk of IOL calcifications, although the mechanism is still unknown. Hydrophilic IOLs have greater ease of manipulation, greater resistance to IOL damage, and higher uveal biocompatibility. Hydrophobic IOLs show better PCO prevention than hydrophilic IOLs, and should be preferred in highly myopic eyes where Nd:YAG capsulotomy might increase the risk of retinal detachment.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cataract surgery with endothelial keratoplasty. 白内障手术与内皮角膜移植术。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-17 DOI: 10.1097/ICU.0000000000001094
Muhammad A Ahad, Sara M AlHilali, Deema E Jomar

Purpose of review: This review aims to provide an updated summary of the combined approach of cataract surgery with endothelial keratoplasty (EK), addressing key considerations, including intraocular lens (IOL) choice and calculation, decision between sequential and triple EK, and modifications in surgical techniques and postoperative management.

Recent findings: Advances in imaging techniques (Scheimpflug tomography and anterior segment optical coherence tomography) have improved the ability to detect subclinical corneal edema, aiding in surgical decision-making for EK. Recent studies comparing sequential and triple-EK indicate that both methods yield similar visual outcomes. Though triple-EK offers quicker recovery, it may have higher complication rates. The use of gases like SF6 and C3F8 for anterior chamber tamponade is evolving, with conflicting findings on their efficacy in preventing graft detachment. Furthermore, IOL selection remains crucial, as hyperopic refractive surprises are common, and hydrophilic lenses should be avoided owing to the risk of opacification after EK.

Summary: The combination of cataract surgery with EK has emerged as an effective treatment for patients with corneal endothelial diseases and cataract. Careful preoperative evaluation, appropriate IOL selection, and advances in surgical techniques contribute to better outcomes, although patient-specific factors must guide the choice between sequential and triple-EK procedures.

综述目的:本综述旨在对白内障手术与内皮角膜移植术(EK)的联合方法进行最新总结,探讨关键注意事项,包括眼内人工晶体(IOL)的选择和计算、顺序EK和三重EK之间的决定,以及手术技术和术后管理的修改:成像技术(Scheimpflug断层扫描和前段光学相干断层扫描)的进步提高了检测亚临床角膜水肿的能力,有助于角膜屈光手术的决策。最近对顺序角膜屈光手术和三重角膜屈光手术进行比较的研究表明,两种方法产生的视觉效果相似。虽然三联 EK 恢复更快,但并发症发生率可能更高。使用 SF6 和 C3F8 等气体进行前房填塞的方法也在不断发展,但关于这些气体在防止移植物脱离方面的功效,研究结果并不一致。此外,人工晶体的选择仍然至关重要,因为远视性屈光意外很常见,而且亲水性人工晶体在角膜屈光手术后有发生混浊的风险,因此应避免使用。摘要:白内障手术与角膜屈光手术的结合已成为角膜内皮疾病和白内障患者的有效治疗方法。仔细的术前评估、适当的人工晶体选择以及手术技术的进步有助于获得更好的疗效,但患者的具体因素必须指导患者在连续手术和三重角膜屈光手术之间做出选择。
{"title":"Cataract surgery with endothelial keratoplasty.","authors":"Muhammad A Ahad, Sara M AlHilali, Deema E Jomar","doi":"10.1097/ICU.0000000000001094","DOIUrl":"https://doi.org/10.1097/ICU.0000000000001094","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review aims to provide an updated summary of the combined approach of cataract surgery with endothelial keratoplasty (EK), addressing key considerations, including intraocular lens (IOL) choice and calculation, decision between sequential and triple EK, and modifications in surgical techniques and postoperative management.</p><p><strong>Recent findings: </strong>Advances in imaging techniques (Scheimpflug tomography and anterior segment optical coherence tomography) have improved the ability to detect subclinical corneal edema, aiding in surgical decision-making for EK. Recent studies comparing sequential and triple-EK indicate that both methods yield similar visual outcomes. Though triple-EK offers quicker recovery, it may have higher complication rates. The use of gases like SF6 and C3F8 for anterior chamber tamponade is evolving, with conflicting findings on their efficacy in preventing graft detachment. Furthermore, IOL selection remains crucial, as hyperopic refractive surprises are common, and hydrophilic lenses should be avoided owing to the risk of opacification after EK.</p><p><strong>Summary: </strong>The combination of cataract surgery with EK has emerged as an effective treatment for patients with corneal endothelial diseases and cataract. Careful preoperative evaluation, appropriate IOL selection, and advances in surgical techniques contribute to better outcomes, although patient-specific factors must guide the choice between sequential and triple-EK procedures.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Foundation models in ophthalmology: opportunities and challenges. 眼科基础模式:机遇与挑战。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-26 DOI: 10.1097/ICU.0000000000001091
Mertcan Sevgi, Eden Ruffell, Fares Antaki, Mark A Chia, Pearse A Keane

Purpose of review: Last year marked the development of the first foundation model in ophthalmology, RETFound, setting the stage for generalizable medical artificial intelligence (GMAI) that can adapt to novel tasks. Additionally, rapid advancements in large language model (LLM) technology, including models such as GPT-4 and Gemini, have been tailored for medical specialization and evaluated on clinical scenarios with promising results. This review explores the opportunities and challenges for further advancements in these technologies.

Recent findings: RETFound outperforms traditional deep learning models in specific tasks, even when only fine-tuned on small datasets. Additionally, LMMs like Med-Gemini and Medprompt GPT-4 perform better than out-of-the-box models for ophthalmology tasks. However, there is still a significant deficiency in ophthalmology-specific multimodal models. This gap is primarily due to the substantial computational resources required to train these models and the limitations of high-quality ophthalmology datasets.

Summary: Overall, foundation models in ophthalmology present promising opportunities but face challenges, particularly the need for high-quality, standardized datasets for training and specialization. Although development has primarily focused on large language and vision models, the greatest opportunities lie in advancing large multimodal models, which can more closely mimic the capabilities of clinicians.

回顾的目的:去年,眼科领域开发出首个基础模型 RETFound,为可适应新任务的通用医学人工智能(GMAI)奠定了基础。此外,包括 GPT-4 和 Gemini 等模型在内的大型语言模型(LLM)技术也取得了突飞猛进的发展,这些模型已针对医学专业进行了定制,并在临床场景中进行了评估,取得了可喜的成果。本综述探讨了这些技术进一步发展的机遇和挑战:RETFound 在特定任务中的表现优于传统的深度学习模型,即使仅在小型数据集上进行微调也是如此。此外,Med-Gemini 和 Medprompt GPT-4 等 LMM 在眼科任务中的表现优于开箱即用的模型。然而,眼科专用的多模态模型仍然存在很大的不足。总结:总体而言,眼科基础模型带来了良好的机遇,但也面临着挑战,特别是需要高质量、标准化的数据集来进行训练和专业化。虽然开发工作主要集中在大型语言和视觉模型上,但最大的机遇在于推进大型多模态模型的开发,因为这些模型能更接近临床医生的能力。
{"title":"Foundation models in ophthalmology: opportunities and challenges.","authors":"Mertcan Sevgi, Eden Ruffell, Fares Antaki, Mark A Chia, Pearse A Keane","doi":"10.1097/ICU.0000000000001091","DOIUrl":"10.1097/ICU.0000000000001091","url":null,"abstract":"<p><strong>Purpose of review: </strong>Last year marked the development of the first foundation model in ophthalmology, RETFound, setting the stage for generalizable medical artificial intelligence (GMAI) that can adapt to novel tasks. Additionally, rapid advancements in large language model (LLM) technology, including models such as GPT-4 and Gemini, have been tailored for medical specialization and evaluated on clinical scenarios with promising results. This review explores the opportunities and challenges for further advancements in these technologies.</p><p><strong>Recent findings: </strong>RETFound outperforms traditional deep learning models in specific tasks, even when only fine-tuned on small datasets. Additionally, LMMs like Med-Gemini and Medprompt GPT-4 perform better than out-of-the-box models for ophthalmology tasks. However, there is still a significant deficiency in ophthalmology-specific multimodal models. This gap is primarily due to the substantial computational resources required to train these models and the limitations of high-quality ophthalmology datasets.</p><p><strong>Summary: </strong>Overall, foundation models in ophthalmology present promising opportunities but face challenges, particularly the need for high-quality, standardized datasets for training and specialization. Although development has primarily focused on large language and vision models, the greatest opportunities lie in advancing large multimodal models, which can more closely mimic the capabilities of clinicians.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review and analysis of history and utilization of panretinal photocoagulation and ranibizumab after publication of protocol S. 在 S.方案公布后,对泛视网膜光凝术和雷尼珠单抗的历史和使用情况进行回顾和分析。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-12 DOI: 10.1097/ICU.0000000000001076
Serena Shah, Brandon Chou, Marissa Patel, Arjun Watane, Lea Shah, Nicolas Yannuzzi, Jayanth Sridhar

Purpose of review: We describe the history, utilization, and series results of panretinal photocoagulation (PRP) and ranibizumab and provide an analysis of PRP and ranibizumab usage before versus after the publication of the 2-year and 5-year results of the Diabetic Retinopathy Clinical Research Network (DRCR.net) Protocol S trial.

Recent findings: Number of ranibizumabs performed began to increase and number of PRPs performed began to decrease in 2016. After publication of the 2-year results, there was significant negative trend in PRP services and significant positive trend in ranibizumab services (both P < 0.001). After publication of the 5-year results, there was significant negative trend in PRP services (P = 0.003). There were significant negative trends (all P < 0.001) in reimbursement factors for PRP from 2013 to 2020: average work RVU (wRVU), nonfacility physical expense RVU, facility PE RVU, malpractice RVU (MP RVU).

Summary: Both PRP and ranibizumab have undergone numerous trials comparing their efficacy to other treatment options or no treatment at all. The publication of the 2-year results of Protocol S was associated with an increase in utilization of ranibizumab and decrease in utilization of PRP, with continued decrease after the publication of the 5-year results.

综述目的:我们描述了泛视网膜光凝(PRP)和雷尼珠单抗的历史、使用情况和系列结果,并对糖尿病视网膜病变临床研究网络(DRCR.net)S协议试验2年和5年结果公布前后的PRP和雷尼珠单抗使用情况进行了分析:2016年,雷尼布单抗的使用次数开始增加,PRP的使用次数开始减少。2 年结果公布后,PRP 服务呈显著的负趋势,而雷尼珠单抗服务呈显著的正趋势(均为 P 摘要:PRP 和雷尼珠单抗都经过了大量试验,比较了它们与其他治疗方案或根本不进行治疗的疗效。S 方案 2 年结果公布后,使用雷尼珠单抗的人数增加,使用 PRP 的人数减少,5 年结果公布后,使用 PRP 的人数继续减少。
{"title":"Review and analysis of history and utilization of panretinal photocoagulation and ranibizumab after publication of protocol S.","authors":"Serena Shah, Brandon Chou, Marissa Patel, Arjun Watane, Lea Shah, Nicolas Yannuzzi, Jayanth Sridhar","doi":"10.1097/ICU.0000000000001076","DOIUrl":"https://doi.org/10.1097/ICU.0000000000001076","url":null,"abstract":"<p><strong>Purpose of review: </strong>We describe the history, utilization, and series results of panretinal photocoagulation (PRP) and ranibizumab and provide an analysis of PRP and ranibizumab usage before versus after the publication of the 2-year and 5-year results of the Diabetic Retinopathy Clinical Research Network (DRCR.net) Protocol S trial.</p><p><strong>Recent findings: </strong>Number of ranibizumabs performed began to increase and number of PRPs performed began to decrease in 2016. After publication of the 2-year results, there was significant negative trend in PRP services and significant positive trend in ranibizumab services (both P < 0.001). After publication of the 5-year results, there was significant negative trend in PRP services (P = 0.003). There were significant negative trends (all P < 0.001) in reimbursement factors for PRP from 2013 to 2020: average work RVU (wRVU), nonfacility physical expense RVU, facility PE RVU, malpractice RVU (MP RVU).</p><p><strong>Summary: </strong>Both PRP and ranibizumab have undergone numerous trials comparing their efficacy to other treatment options or no treatment at all. The publication of the 2-year results of Protocol S was associated with an increase in utilization of ranibizumab and decrease in utilization of PRP, with continued decrease after the publication of the 5-year results.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":"35 5","pages":"369-375"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141903470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The necessity and role of scleral buckling for rhegmatogenous retinal detachment. 巩膜扣带术治疗流变性视网膜脱离的必要性和作用。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-05-31 DOI: 10.1097/ICU.0000000000001065
Kristine Y Wang, Olufemi E Adams, Michael D Yu, Yoshihiro Yonekawa

Purpose of review: With a decline in the use of scleral buckling for rhegmatogenous retinal detachment (RRD) repair in recent years, this review seeks to provide a summary of the most recent research findings regarding the role of scleral buckling in the repair of RRD.

Recent findings: Many recent studies have compared visual and anatomic outcomes between scleral buckling and pars plana vitrectomy (PPV) for RRD repair. Some suggest superior outcomes with primary scleral buckling, particularly in younger, phakic patients, and in association with other risk factors that we review. Children do best with primary scleral buckling surgery. Functionally, scleral buckling may also result in lower rates of retinal displacement compared to PPV. When PPV is necessary, a supplemental buckle may benefit certain patients, while the advantage remains unclear in other clinical scenarios and necessitates further investigation.

Summary: Scleral buckling is an important technique for the repair of RRD and it is crucial to continue training retina surgeons in this technique to maximize patient outcomes.

综述的目的:近年来,流变性视网膜脱离(RRD)修复术中使用巩膜扣带术的情况有所减少,本综述旨在总结有关巩膜扣带术在RRD修复术中作用的最新研究成果:最近的许多研究比较了巩膜扣带术和玻璃体旁切除术(PPV)在RRD修复中的视觉和解剖效果。一些研究表明,初次巩膜扣带术的疗效更佳,尤其是对于年轻的无晶体眼患者,以及与其他风险因素相关的患者,我们对此进行了综述。儿童接受初级巩膜扣锁手术的效果最好。从功能上讲,巩膜扣带术后视网膜移位的发生率也低于 PPV。总结:巩膜扣带术是修复 RRD 的一项重要技术,继续培训视网膜外科医生掌握这项技术以最大限度地提高患者的治疗效果至关重要。
{"title":"The necessity and role of scleral buckling for rhegmatogenous retinal detachment.","authors":"Kristine Y Wang, Olufemi E Adams, Michael D Yu, Yoshihiro Yonekawa","doi":"10.1097/ICU.0000000000001065","DOIUrl":"10.1097/ICU.0000000000001065","url":null,"abstract":"<p><strong>Purpose of review: </strong>With a decline in the use of scleral buckling for rhegmatogenous retinal detachment (RRD) repair in recent years, this review seeks to provide a summary of the most recent research findings regarding the role of scleral buckling in the repair of RRD.</p><p><strong>Recent findings: </strong>Many recent studies have compared visual and anatomic outcomes between scleral buckling and pars plana vitrectomy (PPV) for RRD repair. Some suggest superior outcomes with primary scleral buckling, particularly in younger, phakic patients, and in association with other risk factors that we review. Children do best with primary scleral buckling surgery. Functionally, scleral buckling may also result in lower rates of retinal displacement compared to PPV. When PPV is necessary, a supplemental buckle may benefit certain patients, while the advantage remains unclear in other clinical scenarios and necessitates further investigation.</p><p><strong>Summary: </strong>Scleral buckling is an important technique for the repair of RRD and it is crucial to continue training retina surgeons in this technique to maximize patient outcomes.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"376-381"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141184995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eco-sustainability in ophthalmology. 眼科的生态可持续性。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-24 DOI: 10.1097/ICU.0000000000001070
Gabriela G Lee, Matteo Menean, Basil K Williams, Maura Di Nicola

Purpose of review: The purpose of this review is to evaluate the current state of eco-sustainability in ophthalmology, highlighting key practices, recent advancements, and areas requiring improvement. This review aims to provide ophthalmologists with a comprehensive overview of sustainable practices that can reduce environmental impact.

Recent findings: Recent studies have identified several areas within ophthalmology where sustainable practices can be implemented including multidose eyedrops, adjusting surgical packs, making package inserts available electronically, and reusing surgical instruments. Moreover, there is an increasing emphasis on waste reduction both in the surgical and clinical setting, by decreasing the use of unnecessary materials and implementing more efficient use of recycling programs. Telemedicine has also emerged as a sustainable option, reducing the carbon footprint associated with patient travel. Despite these advancements, significant challenges remain, particularly in balancing the cost and accessibility of sustainable options with traditional practices.

Summary: Eco-sustainability in ophthalmology is gaining momentum as the medical community aims to reduce its environmental impact. While progress has been made, further efforts are required to overcome financial and logistical barriers to widespread implementation. Continued research, education, and policy development are essential to advancing eco-sustainable practices, ensuring that environmental considerations become an integral part of ophthalmic care.

综述目的:本综述旨在评估眼科生态可持续发展的现状,突出关键实践、最新进展和需要改进的领域。本综述旨在向眼科医生全面介绍可减少环境影响的可持续实践:最近的研究发现,眼科有几个领域可以实施可持续发展实践,包括多剂量眼药水、调整手术包、提供电子包装插页以及重复使用手术器械。此外,通过减少不必要材料的使用和实施更有效的回收利用计划,减少手术和临床环境中的浪费也日益受到重视。远程医疗也已成为一种可持续的选择,减少了与病人旅行相关的碳足迹。尽管取得了这些进步,但仍面临着巨大的挑战,尤其是如何在可持续发展方案的成本和可及性与传统做法之间取得平衡。摘要:随着医学界致力于减少对环境的影响,眼科领域的生态可持续性发展势头日益强劲。虽然已经取得了一些进展,但仍需进一步努力,以克服广泛实施过程中的资金和后勤障碍。持续的研究、教育和政策制定对于推进生态可持续实践至关重要,可确保环境因素成为眼科护理不可或缺的一部分。
{"title":"Eco-sustainability in ophthalmology.","authors":"Gabriela G Lee, Matteo Menean, Basil K Williams, Maura Di Nicola","doi":"10.1097/ICU.0000000000001070","DOIUrl":"10.1097/ICU.0000000000001070","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to evaluate the current state of eco-sustainability in ophthalmology, highlighting key practices, recent advancements, and areas requiring improvement. This review aims to provide ophthalmologists with a comprehensive overview of sustainable practices that can reduce environmental impact.</p><p><strong>Recent findings: </strong>Recent studies have identified several areas within ophthalmology where sustainable practices can be implemented including multidose eyedrops, adjusting surgical packs, making package inserts available electronically, and reusing surgical instruments. Moreover, there is an increasing emphasis on waste reduction both in the surgical and clinical setting, by decreasing the use of unnecessary materials and implementing more efficient use of recycling programs. Telemedicine has also emerged as a sustainable option, reducing the carbon footprint associated with patient travel. Despite these advancements, significant challenges remain, particularly in balancing the cost and accessibility of sustainable options with traditional practices.</p><p><strong>Summary: </strong>Eco-sustainability in ophthalmology is gaining momentum as the medical community aims to reduce its environmental impact. While progress has been made, further efforts are required to overcome financial and logistical barriers to widespread implementation. Continued research, education, and policy development are essential to advancing eco-sustainable practices, ensuring that environmental considerations become an integral part of ophthalmic care.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"403-408"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive, maximally impactful: minimally invasive glaucoma surgery and the changing glaucoma landscape. 微创,影响最大:微创青光眼手术和不断变化的青光眼形势。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-29 DOI: 10.1097/ICU.0000000000001077
Arjun Sharma, Jonathan D Tijerina, Elena Bitrian

Purpose of review: The advent of minimally invasive glaucoma surgery (MIGS) procedures has ushered in a new era of interventional glaucoma. MIGS has expanded the treatment options for surgeons necessitating a rethinking of the optimal management strategy for patients with glaucoma.

Recent findings: There are several new MIGS devices and procedures available to glaucoma surgeons. With several options available, patient selection is crucial to maximize the utility of MIGS in the context of traditional glaucoma surgery.

Summary: A management algorithm is presented based on our practice pattern to help guide decision-making for glaucoma surgeons. Although we encourage surgeons to continue to broaden their toolkit, we emphasize the continued importance of teaching the next-generation traditional glaucoma surgery in the MIGS era. Future prospective studies are warranted to elucidate the optimal treatment strategy for patients with glaucoma.

综述的目的:微创青光眼手术(MIGS)的出现开创了介入性青光眼的新时代。微创青光眼手术扩大了外科医生的治疗选择范围,因此有必要重新思考青光眼患者的最佳治疗策略:青光眼外科医生可以使用多种新型 MIGS 设备和手术。摘要:根据我们的实践模式提出了一种管理算法,以帮助指导青光眼外科医生做出决策。尽管我们鼓励外科医生继续拓宽他们的工具包,但我们强调在 MIGS 时代教授新一代传统青光眼手术仍然非常重要。未来有必要开展前瞻性研究,以阐明青光眼患者的最佳治疗策略。
{"title":"Minimally invasive, maximally impactful: minimally invasive glaucoma surgery and the changing glaucoma landscape.","authors":"Arjun Sharma, Jonathan D Tijerina, Elena Bitrian","doi":"10.1097/ICU.0000000000001077","DOIUrl":"10.1097/ICU.0000000000001077","url":null,"abstract":"<p><strong>Purpose of review: </strong>The advent of minimally invasive glaucoma surgery (MIGS) procedures has ushered in a new era of interventional glaucoma. MIGS has expanded the treatment options for surgeons necessitating a rethinking of the optimal management strategy for patients with glaucoma.</p><p><strong>Recent findings: </strong>There are several new MIGS devices and procedures available to glaucoma surgeons. With several options available, patient selection is crucial to maximize the utility of MIGS in the context of traditional glaucoma surgery.</p><p><strong>Summary: </strong>A management algorithm is presented based on our practice pattern to help guide decision-making for glaucoma surgeons. Although we encourage surgeons to continue to broaden their toolkit, we emphasize the continued importance of teaching the next-generation traditional glaucoma surgery in the MIGS era. Future prospective studies are warranted to elucidate the optimal treatment strategy for patients with glaucoma.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"409-414"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141856981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment for dry age-related macular degeneration: where we stand in 2024. 干性老年性黄斑变性的治疗:2024 年的现状。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-13 DOI: 10.1097/ICU.0000000000001064
Sydney Wheeler, Raziyeh Mahmoudzadeh, Jessica Randolph

Purpose of review: This review highlights treatment options, both under investigation and currently available, for the treatment of dry age-related macular degeneration (AMD). An update on current clinical studies for dry AMD has been summarized.

Recent findings: Advanced dry AMD, characterized by geographic atrophy (GA), is a leading cause of blindness in the developed world, though prior to 2023 there was no approved treatment. There are now two approved treatments in the United States for GA. Additionally, there are several studies and trials to investigate therapeutic potential and effects of therapies for earlier intervention in dry AMD. Approaches to therapy include inhibiting the complement system, utilizing gene therapy, stem cell therapy, laser therapy, and surgical implants.

Summary: While there has been notable prior advancement in the treatment for neovascular or wet AMD, for the first time there are Food and Drug Administration (FDA) approved treatments for GA. Clinical studies have shown promise for additional methods for managing dry AMD both medically and surgically.

综述目的:本综述重点介绍了治疗干性老年性黄斑变性(AMD)的研究中和现有的治疗方案。还总结了当前干性黄斑变性临床研究的最新进展:以地理萎缩(GA)为特征的晚期干性黄斑变性是发达国家致盲的主要原因之一,但在 2023 年之前还没有获得批准的治疗方法。目前,美国已批准了两种治疗 GA 的方法。此外,还有一些研究和试验正在调查早期干预干性老年黄斑变性的治疗潜力和效果。治疗方法包括抑制补体系统、利用基因疗法、干细胞疗法、激光疗法和手术植入等。摘要:虽然之前在治疗新生血管性或湿性 AMD 方面取得了显著进展,但美国食品和药物管理局(FDA)首次批准了治疗 GA 的方法。临床研究显示,通过药物和手术治疗干性老年黄斑变性的其他方法前景看好。
{"title":"Treatment for dry age-related macular degeneration: where we stand in 2024.","authors":"Sydney Wheeler, Raziyeh Mahmoudzadeh, Jessica Randolph","doi":"10.1097/ICU.0000000000001064","DOIUrl":"10.1097/ICU.0000000000001064","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review highlights treatment options, both under investigation and currently available, for the treatment of dry age-related macular degeneration (AMD). An update on current clinical studies for dry AMD has been summarized.</p><p><strong>Recent findings: </strong>Advanced dry AMD, characterized by geographic atrophy (GA), is a leading cause of blindness in the developed world, though prior to 2023 there was no approved treatment. There are now two approved treatments in the United States for GA. Additionally, there are several studies and trials to investigate therapeutic potential and effects of therapies for earlier intervention in dry AMD. Approaches to therapy include inhibiting the complement system, utilizing gene therapy, stem cell therapy, laser therapy, and surgical implants.</p><p><strong>Summary: </strong>While there has been notable prior advancement in the treatment for neovascular or wet AMD, for the first time there are Food and Drug Administration (FDA) approved treatments for GA. Clinical studies have shown promise for additional methods for managing dry AMD both medically and surgically.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"359-364"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141318909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Criteria for premium intraocular lens patient selection. 选择优质眼内透镜患者的标准。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-13 DOI: 10.1097/ICU.0000000000001067
Jacqueline L Chen, Zaina N Al-Mohtaseb, Allison J Chen

Purpose of review: To discuss available premium intraocular lenses (IOLs), patient selection, and important considerations for each premium IOL.

Recent findings: We review important topics and considerations for premium IOL selection: specifically, toric, extended depth of focus (EDOF), multifocal/trifocal, light adjustable lenses (LALs), and small aperture IOLs. Toric lenses are an excellent option for patients with astigmatism. However, to achieve optimal patient satisfaction, it is critical to account for the ATR astigmatism contribution from the posterior cornea and high angle alphas. Additionally, examining the ocular surface prior to placement of EDOF/multifocal IOLs is important, yet the significance of HOAs on outcomes after implantation still must be elucidated more. Finally, recent studies reveal that the small aperture lens is a good alternative for those with corneal irregularities, and second generation LALs are a great option to achieve target refractions in those with less predictable refractive outcomes, such as in Fuchs' dystrophy or in eyes with previous refractive surgery.

综述目的:讨论现有的优质眼内人工晶体(IOL)、患者选择以及每种优质人工晶体的重要注意事项:我们回顾了选择优质人工晶体的重要主题和注意事项:特别是散光、延长焦距深度 (EDOF)、多焦点/三焦点、光调节镜片 (LAL) 和小孔径人工晶体。散光镜片是散光患者的最佳选择。然而,要达到最佳的患者满意度,关键是要考虑到后角膜和高角alphas造成的ATR散光。此外,在植入 EDOF/多焦 IOL 之前检查眼表也很重要,但仍需进一步阐明 HOAs 对植入后疗效的影响。最后,最近的研究表明,对于角膜不规则的患者来说,小孔径人工晶体是一个很好的选择,而对于那些屈光结果不那么容易预测的患者,例如福氏角膜营养不良症患者或曾经接受过屈光手术的患者来说,第二代 LALs 是实现目标屈光度的一个很好的选择。
{"title":"Criteria for premium intraocular lens patient selection.","authors":"Jacqueline L Chen, Zaina N Al-Mohtaseb, Allison J Chen","doi":"10.1097/ICU.0000000000001067","DOIUrl":"10.1097/ICU.0000000000001067","url":null,"abstract":"<p><strong>Purpose of review: </strong>To discuss available premium intraocular lenses (IOLs), patient selection, and important considerations for each premium IOL.</p><p><strong>Recent findings: </strong>We review important topics and considerations for premium IOL selection: specifically, toric, extended depth of focus (EDOF), multifocal/trifocal, light adjustable lenses (LALs), and small aperture IOLs. Toric lenses are an excellent option for patients with astigmatism. However, to achieve optimal patient satisfaction, it is critical to account for the ATR astigmatism contribution from the posterior cornea and high angle alphas. Additionally, examining the ocular surface prior to placement of EDOF/multifocal IOLs is important, yet the significance of HOAs on outcomes after implantation still must be elucidated more. Finally, recent studies reveal that the small aperture lens is a good alternative for those with corneal irregularities, and second generation LALs are a great option to achieve target refractions in those with less predictable refractive outcomes, such as in Fuchs' dystrophy or in eyes with previous refractive surgery.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"353-358"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of oculoplastic surgeons in minimally invasive cosmetic injectables. 眼部整形外科医生在微创注射美容中的作用。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-27 DOI: 10.1097/ICU.0000000000001068
Elana Meer, Jacqueline Lopez, Jonathan Lu, Bryan J Winn, Seanna R Grob

Purpose of review: In recent years, the field of aesthetic medicine has witnessed a paradigm shift with an increasing demand for minimally invasive cosmetic procedures, including cosmetic injectables. This review aims to delineate the distinctive role played by oculoplastic surgeons in the administration of cosmetic injectables, comparing their expertise to that of nonphysician practitioners.

Recent findings: Complications arising from cosmetic injections are discussed, including skin discoloration, inflammation, necrosis, vision loss, retinal pathology, and central nervous system adverse effects. Injector expertise, patient factors, type of filler, location of injection, and management strategies are reviewed. Findings highlight diverse practitioner involvement, common adverse effects like skin necrosis and vision loss, with hyaluronic acid fillers being prominent. Areas at the highest risk for ocular complication include the glabella and nose with potential management involving dissolving fillers and reducing pressure. Emphasis is placed on expert injector selection and patient awareness.

Summary: The administration of cosmetic injectables requires a profound understanding of facial anatomy, vasculature, and potential complications. In contrast to nonphysician practitioners, oculoplastic and aesthetic surgeons bring a level of anatomical precision and clinical acumen that is essential for navigating the complexities of cosmetic injectables. Emphasis on training and collaboration among practitioners will be essential in advancing the field while prioritizing patient safety and satisfaction.

综述目的:近年来,随着对微创美容手术(包括注射美容)的需求不断增加,美容医学领域的模式发生了转变。这篇综述旨在阐述眼部整形外科医生在注射美容方面发挥的独特作用,并将他们的专业知识与非医生从业者的专业知识进行比较:讨论了注射美容引起的并发症,包括皮肤变色、炎症、坏死、视力下降、视网膜病变和中枢神经系统不良反应。回顾了注射者的专业知识、患者因素、填充物类型、注射位置和处理策略。研究结果强调了不同从业人员的参与、皮肤坏死和视力下降等常见不良反应,其中透明质酸填充剂的不良反应最为突出。眼部并发症风险最高的部位包括眉间和鼻部,可能的处理方法包括溶解填充物和减少压力。小结:注射美容需要对面部解剖、血管和潜在并发症有深刻的了解。与非医师从业者相比,眼部整形和美容外科医生具有解剖学上的精确性和临床敏锐性,这对于驾驭复杂的注射美容至关重要。在优先考虑患者安全和满意度的同时,强调从业人员之间的培训和合作对于推动这一领域的发展至关重要。
{"title":"The role of oculoplastic surgeons in minimally invasive cosmetic injectables.","authors":"Elana Meer, Jacqueline Lopez, Jonathan Lu, Bryan J Winn, Seanna R Grob","doi":"10.1097/ICU.0000000000001068","DOIUrl":"10.1097/ICU.0000000000001068","url":null,"abstract":"<p><strong>Purpose of review: </strong>In recent years, the field of aesthetic medicine has witnessed a paradigm shift with an increasing demand for minimally invasive cosmetic procedures, including cosmetic injectables. This review aims to delineate the distinctive role played by oculoplastic surgeons in the administration of cosmetic injectables, comparing their expertise to that of nonphysician practitioners.</p><p><strong>Recent findings: </strong>Complications arising from cosmetic injections are discussed, including skin discoloration, inflammation, necrosis, vision loss, retinal pathology, and central nervous system adverse effects. Injector expertise, patient factors, type of filler, location of injection, and management strategies are reviewed. Findings highlight diverse practitioner involvement, common adverse effects like skin necrosis and vision loss, with hyaluronic acid fillers being prominent. Areas at the highest risk for ocular complication include the glabella and nose with potential management involving dissolving fillers and reducing pressure. Emphasis is placed on expert injector selection and patient awareness.</p><p><strong>Summary: </strong>The administration of cosmetic injectables requires a profound understanding of facial anatomy, vasculature, and potential complications. In contrast to nonphysician practitioners, oculoplastic and aesthetic surgeons bring a level of anatomical precision and clinical acumen that is essential for navigating the complexities of cosmetic injectables. Emphasis on training and collaboration among practitioners will be essential in advancing the field while prioritizing patient safety and satisfaction.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"382-390"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1